Public-registry trials using BTI320 that Eichor's radar has found — 1 trial. All data below is from public sources; Eichor is not affiliated with any sponsor.
| Trial | Sponsor | Condition | Phase | Sites |
| Multicenter Study to Evaluate the Effect of BTI320 on Glycemic Control in Type 2 Diabetes | Boston Therapeutics | Type2 Diabetes Mellitus | PHASE2 | 4 |
| First registered study | February 2015 — NCT02358668 (Chinese University of Hong Kong) |
| Registered studies matching this name | 4 all-time · 0 currently recruiting |
Source: ClinicalTrials.gov, the public trial registry.
Eichor generates a preliminary site-risk snapshot — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →
← Eichor home · All tracked trials · Type2 Diabetes Mellitus studies · Weekly briefs